Clinical Trials Browser

INDUSTRY × Margins of Excision × Clear all

NCT06618170 2024-10-02

ETCETERA

Not yet recruiting

Margins of Excision, Carcinoma, Head and Neck Neoplasms

NCT06020573 2024-09-05

Evaluation of Safety and Performance of Intraoperative Detection of Light Signals During Electrosurgical Breast Cancer Resection

Phase NA Completed

Margins of Excision, Breast Neoplasms

NCT05456373 2023-03-22

Intraoperative Use of ClearEdge Device in Breast Conserving Surgery

Phase NA Unknown

Margins of Excision, Breast Neoplasms

NCT04683120 2021-06-30

Real-time Diagnosis and Visualization of Tumor Margins in Excised Breast Specimens Using Zenith FLIM Diagnostics

Phase NA Suspended

Margins of Excision, Breast Neoplasms, Neoplasms

NCT01460134 2018-01-31

A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

Phase 1 Completed

DermatologicGenitourinaryGynecologicLymphoidOther hematologic neoplasmThoracic

Margins of Excision, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Ovarian Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT00719264 2017-03-20

Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer

Phase 2 Completed

365 enrolled 14 charts

Margins of Excision, Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell